Anupam Rasayan India Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹806 Cr +10.3% YoYSee revenue, profit and what management said. You are viewing Q4 FY25.
AR

Anupam Rasayan India Ltd

Q4 FY25Chemicals & Petrochemicals

Anupam Rasayan India Q4 FY25 earnings call: Revenue & Margins

Q4 FY25 earnings call: what management said on revenue, margins and capex.

Revenue
₹500Cr
+24.7% YoY
+28.2% QoQ
Net profit
₹63Cr
+57.5% YoY
+16.7% QoQ
Margin
29%
+6 pp YoY
−3 pp QoQ
Price₹1,244
Market cap₹13.8K Cr
P/E81.4

The short version

Company targets a return to historical revenue growth rates of 25%-30%+ from FY '26 onwards. - Majority of LOIs worth approx. Company targets a return to historical growth rates of 25-30%+ from FY '26 onwards.

From Anupam Rasayan India Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Company targets a return to historical revenue growth rates of 25%-30%+ from FY '26 onwards.
  • Majority of LOIs worth approx. INR14,600 crores will commercialize over 4-10 years, contributing ~INR2,000 crores annual incremental revenue over 2-3 years.
  • New product ramp-ups, especially in Pharma (20%-25% of revenue in FY '26) and Polymer/Performance Chemicals (expected to rise to 25%+ revenue in FY '26), plus recovery in agrochemicals expected to drive volume growth.
  • Agrochemical demand is rebounding with volume-led growth; new high-value AI molecules contribute significantly with triple-digit dollar per kg pricing.
  • Volume, rather than price, is expected to drive growth; pricing impact is minimal.

2 more points from Anupam Rasayan India Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Anupam Rasayan India Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • No additional capex required for servicing the first 1,000 tons of demand for the new AI product; this will be met with current capacities.
  • Potential capex will be considered only upon ramp-up or securing a take-or-pay contract for higher volumes.
  • Current assets can support production worth INR60-70 crores annually for Elementium orders; possible debottlenecking can increase this to INR100 crores without major capex.
  • For scaling Elementium's full potential (approx. $70-$90 million revenue p.a.), significant capex will be necessary.
  • INR670 crores of planned capex completed, with two manufacturing facilities commercialized and one facility ready for commercialization imminently.
  • Capex will focus on expanding production capacity to support next-phase growth and new molecule launches.

2 more points from Anupam Rasayan India Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Anupam Rasayan India Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • Current order book stands at approximately INR 14,646 crores, spread over 4 to 10 years.
  • Out of this, INR 3,100 crores worth of LOIs and contracts have already been commercialized.
  • These commercialized orders contribute to over 20% of revenue in FY '25.
  • Majority of the remaining LOIs and contracts are expected to be commercialized in FY '26.
  • A significant LOI product in the agrochemical segment (an AI molecule) was signed in Q4 2022 and is currently ramping up, expected to contribute triple-digit million dollar revenue.

2 more points from Anupam Rasayan India Ltd's call on order book

Create a free account to keep reading this call

Anupam Rasayan India Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Anupam Rasayan India Ltd Q4 FY25 results — key figures

Anupam Rasayan India Ltd Q4 FY25 reported results vs Q4 FY24, ₹ crore
₹ CrQ4 FY25Q4 FY24YoYQ3 FY25QoQ
Revenue500401+24.7%390+28.2%
Operating profit (EBITDA)14493+54.8%124+16.1%
Operating margin29%23%+6 pp32%-3 pp
Profit before tax8858+51.7%59+49.2%
Net profit (PAT)6340+57.5%54+16.7%
EPS (₹)4.052.82+43.6%2.56+58.2%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹806 Cr, net profit ₹65 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Atul (Q4 FY25)

    Consolidated revenue from operations for 2024-25: ₹5,583 cr, 18% increase YoY from ₹4,726 cr in 2023-24 (Page 36). Key concall takeaways from Atul Ltd's Q4…

  • Vidhi Specialty (Q4 FY25)

    109.5 Crs, up 40.2% YoY (from Rs. Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q4 FY25 earnings call — and how it ranks against sector…

  • Chemcon Speciality Chemicals (Q4 FY25)

    54.9 Crs, down 8% YoY from Rs. Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.

  • Valiant Organics (Q4 FY25)

    Q4-FY25 revenue from operations (consolidated) was INR 2,038 million, a 15.3% year-on-year (YoY) increase from INR 1,768 million in Q4-FY24 (Page 12 and 10)…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Anupam Rasayan India Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Anupam Rasayan India Ltd Q4 FY25 results?

Company targets a return to historical revenue growth rates of 25%-30%+ from FY '26 onwards. - Majority of LOIs worth approx. Company targets a return to historical growth rates of 25-30%+ from FY '26 onwards.

What is Anupam Rasayan India Ltd share price analysis?

Anupam Rasayan India Ltd currently shows a neutral. The stock trades at a P/E of 81.4 with a market cap of ₹13,847 Cr. Investors should review the full earnings analysis for detailed insights.

Is Anupam Rasayan India Ltd planning capital expenditure?

No additional capex required for servicing the first 1,000 tons of demand for the new AI product; this will be met with current capacities. - Potential capex will be considered only upon ramp-up or securing a take-or-pay contract for higher volumes. - Current assets can support production worth INR60-70 crores annually for Elementium orders; possible debottlenecking can increase this to INR100 crores without major capex. - For scaling Elementium's full potential (approx.

Keep Anupam Rasayan India Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.